A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine (Q33363561)
scientific article
Language:
Current Data About A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine
(P31) (Q13442814)
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P50) (Q87725760)
(P1545) 9
(P1932) M J Ratain
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P304) 1705-1711
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P407) (Q1860)

(P433) 11
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P478) 15
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P577) Monday, November 1, 2004
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P921) (Q420207)
(P887)

(P1433) (Q326122)
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P1476) "A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine" (language: en)
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

(P2093) S D Undevia
(P1545) 1
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

H L Kindler
(P1545) 2
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

L Janisch
(P1545) 3
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

S C Olson
(P1545) 4
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

R L Schilsky
(P1545) 5
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

N J Vogelzang
(P1545) 6
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

K A Kimmel
(P1545) 7
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

T A Macek
(P1545) 8
(P248)
(P698) 15520075
(P813) Wednesday, July 26, 2017

other details